MedTrace Logo

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

NCT03963596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-01-25

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to pathologic myopia.

Conditions

  • Pathologic Myopia

Interventions

PROCEDURE

Intravitreal injection

Intravitreal injection to the regimen pro re nata.

Sponsors & Collaborators

  • Odessa National Medical University

    collaborator OTHER

  • Mykolaiv Region Ophthalmogical Hospital

    collaborator OTHER

  • Central Polyclinic of Internal Affairs of Ukraine

    collaborator OTHER_GOV

  • The Filatov Institute of Eye Diseases and Tissue Therapy

    lead OTHER

Principal Investigators

  • Andrii MD Korol, PhD · The Filatov Institute of Eye Diseases and Tissue Therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2020-07-01
Completion
2020-12-31

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03963596 on ClinicalTrials.gov